Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy (USA)

This study has been completed.
Sponsor:
Collaborator:
Riverside Research Institute
Information provided by (Responsible Party):
Beth Israel Medical Center
ClinicalTrials.gov Identifier:
NCT01227642
First received: October 22, 2010
Last updated: March 11, 2016
Last verified: March 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2014
  Primary Completion Date: August 2014 (Final data collection date for primary outcome measure)
Publications: